Hematology and Oncology
Breast Abnormalities
April 2001
Clinical Focus*
- What are the recommendations for evaluation of breast symptoms, mammographic findings and other suspicious findings based on menstrual status, use of hormone replacement therapy (HRT), pregnancy, age, and family history?
- How are lobular carcinoma in situ (LCIS) and atypical hyperplasia (AH) managed?
- How are nonpalpable lesions and calcifications managed?
- What are the indications for sentinel node biopsy?
- What costs are associated with diagnosis and management of breast disease as outlined above?
*Addressed in the summary or evidence report.
Diagnosis and Management of Specific Breast Abnormalities
Summary (Publication No. 01-E045, April 2001)
Evidence Report (Publication No. 01-E046, September 2001)
(File Download)
EPC: MetaWorks, Inc.
Topic Nominator: Kaiser Permanente, Northern California
Return to Quick Menu: Evidence Report Topics
Return to Evidence-based Practice